Renal cell carcinoma, prostate cancer, bladder cancer
Conditions
Interventions
fluorescence imaging with indocyanine green
Sponsors
SOGA NORIHITO
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. the cases undergoing operation for renal cancer, prostate cancer or bladder cancer, associated with agreement of informed consent for this study, no concerned with clinical staging, historical disease and containing metastasis 2. Aged =<85 years 3.WHO performance status 0 or 1 4.Patients who satisfy the following criteria for the major organ function in tests performed within one month prior to enrollment WBC =/under 3000/mm3 Plt =/over 100,000/mm3 Hgb =/over 8.0g/mm3 Ccr =/over 40ml/m T-Bil =/under 2.0mg/dl AST =/under 2.5xULN ALT =/under 2.5xULN
Exclusion criteria
Exclusion criteria: 1.allergy for the preparation of iodine or allergy to this study drug 2.hepatic and renal dysfunction 3.possibility of side effect induced by dysfunction of clearance of ICG or metabolite of ICG 4.exclusion decided by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of color contrast detect the lymphoid flow | — |
Secondary
| Measure | Time frame |
|---|---|
| safety | — |
Contacts
Public ContactNORIHITO SOGA
Aichi cancer center hospital
Outcome results
None listed